Sw. Bateman et al., Evaluation of point-of-care tests for diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit, J AM VET ME, 215(6), 1999, pp. 805-810
Citations number
29
Categorie Soggetti
Veterinary Medicine/Animal Health
Journal title
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION
Objective-To evaluate the accuracy of point-of-care tests for the diagnosis
of disseminated intravascular coagulation (DIC) in dogs and assess the cor
relation and agreement of results between point-of-care and laboratory test
s in the evaluation of hemostatic function.
Design-Prospective case series.
Animals-59 critically ill dogs (affected dogs) with clinical signs of disea
ses known to predispose to DIC and 52 clinically normal dogs.
Procedures-Accuracy of the point-of-care tests (activated clotting time [AC
T], estimated platelet count and number of schizocytes from a blood smear,
plasma total solids [TS] concentration, and the protamine sulfate test) was
evaluated, using receiver operating characteristic curves and likelihood r
atios. A strategy, using likelihood ratios to calculate a post test probabi
lity of DIG, was tested with 65% used as a threshold for initiation of trea
tment.
Results of laboratory tests (coagulogram and plasma antithrombin III activi
ty) were used as the standard for comparison in each dog. Results-ACT and e
stimated platelet count provided the best accuracy for detection of DIG. Th
e plasma TS concentration, schizocyte number, and protamine sulfate test ha
d poor accuracy. The strategy using post-test probability of DIC identified
12 of 16 affected dogs that had DIG. Estimated platelet count was correlat
ed and had acceptable clinical agreement with automated platelet count (r =
0.70). The plasma TS (r = 0.28) concentration and serum albumin (r = 0.63)
concentration were not accurate predictors of plasma antithrombin III acti
vity. The ACT did not cor relate with activated partial thromboplastin time
(r = 0.28).
Conclusions and Clinical Relevance-Strategic use of likelihood ratios from
point-of-care tests can assist clinicians in making treatment decisions for
dogs suspected to have DIC when immediate laboratory support is unavailabl
e.